Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

New mouse model created for cerebral venous sinus thrombosis

July 26, 2021

Progress in the search for opioid multitarget ligands for persistent pain relief

July 26, 2021

Alzamend reports toxicology results for AL-002 in transgenic mouse model of Alzheimer's disease

July 23, 2021

Targeting IL-3 signaling reduces AD-related pathology

July 23, 2021

Blue Oak Pharmaceuticals describes new antidepressants

July 23, 2021

DSMB recommends continuation of phase II trial of ANVS-401 in Alzheimer's disease

July 21, 2021

Affinia and IOB collaborate to design novel CNS promoters for gene therapy

July 21, 2021

First participants dosed in phase Ib/IIa FOCUSC9 study of WVE-004

July 21, 2021

Acumen initiates phase I study of ACU-193 in mild cognitive impairment or mild Alzheimer's

July 20, 2021

VX-548 enters phase II development for the treatment of acute pain

July 20, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...